An updated meta-analysis to understand the variable efficacy of drotrecogin alfa (activated) in severe sepsis and septic shock

類似資料

• Drotrecogin alfa (activated) may attenuate severe sepsis-associated encephalopathy in clinical septic shock
  著者:: Spapen, Herbert, 等
  出版事項: (2010)
• Three years experience with drotrecogin alfa (activated) protein C in severe sepsis and septic shock at Salmaniya Medical Complex, Bahrain
  著者:: Mohamed, H, 等
  出版事項: (2007)
• Introduction: severe sepsis and drotrecogin alfa (activated)
  著者:: Artigas, Antonio, 等
  出版事項: (2007)
• Why activated Protein C was not successful in severe sepsis and septic shock: Are we still tilting at windmills?
  著者:: Lai, Peggy S., 等
  出版事項: (2013)
• Timing of drotrecogin alfa (activated) treatment in severe sepsis
  著者:: Choi, Goda, 等
  出版事項: (2006)